Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference15 articles.
1. Selonsertib enhances kidney protection beyond standard of care in a hypertensive, secondary glomerulosclerosis CKD model [published online ahead of print April 11, 2022];Badal;Kidney360
2. ASK1-dependent endothelial cell activation is critical in ovarian cancer growth and metastasis;Yin;JCI Insight,2017
3. ASK1 inhibition: A therapeutic strategy with multi-system benefits;Ogier;J Mol Med (Berl),2020
4. ASK1: A new therapeutic target for kidney disease;Tesch;Am J Physiol Renal Physiol,2016
5. Targeting apoptosis signal-regulating kinase 1 in acute and chronic kidney disease;Tesch;Anat Rec (Hoboken),2020
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献